iWorld
Narayana Health launches InsidER medical docu-series with Jio platforms
Mumbai: Narayana Health, a healthcare provider, in association with streaming platform Jio, proudly unveiled India’s first medical docu-series “InsidER” – an innovative initiative on Emergency Awareness. Viewers will witness the intense efforts of clinicians, the profound struggles of families, and the amazing efforts of clinical teams fighting to save lives. All ten episodes feature patients and their families, giving a deeply personal perspective on these powerful stories.
“The ‘InsidER’ campaign was born from a deep-rooted desire to honour the extraordinary courage of patients and the often-unseen daily struggles of families coping with medical emergencies,” said Narayana Health chief marketing officer Dr Ashish Bajaj. “We’re thrilled to join forces with Jio for the launch of this pioneering series added Dr Bajaj. “Their vast reach on Jio TV, Jio Cinema, and Jio TV+ maximizes the impact of this groundbreaking initiative.”
“Over ten months in the making, our teams overcame production challenges across India to authentically portray the gripping reality of the ER. This collaboration with the clinicians, patients & their families paints a powerful picture of those critical moments between life & death and their lasting impact. This series, a first by any healthcare group in the country, is a tribute to those moments, a testament to the strength we hold within, and a reminder of the incredible work done on the frontlines of healthcare. With real patient stories from across India, we have showcased the heart-stopping urgency of the ER, the split-second decisions, and the unbreakable human spirit. The series highlights the clinicians’ preparedness and underscores the importance of knowing the ER number for immediate assistance. Something as simple as knowing your ER number and having it on speed dial could be the difference between life and death.”, he added.
InsidER is backed by extensive research to ensure its medical accuracy. Careful consideration was made to keep each episode under 10 minutes to keep the viewer’s attention without wearing them out. InsidER promises an unforgettable journey into the world of emergency awareness.
With its launch on March 27, “InsidER” stands poised to inform and inspire audiences across the nation, fostering a deeper understanding of emergency medicine, the criticality of the Golden Hour, the importance of knowing CPR, and the unwavering dedication of those who safeguard lives.
iWorld
Bill Ackman’s Pershing Square makes $64 billion bid to acquire Universal Music Group
Ackman pitches NYSE relisting plan as UMG board weighs unsolicited offer
The hedge fund has proposed a business combination that values UMG at €30.40 per share, representing a hefty 78 per cent premium to its current trading price. The offer includes €9.4 billion in cash alongside stock in a newly formed entity, with shareholders set to receive €5.05 per share in cash and 0.77 shares in the new company for each UMG share they hold.
Under the proposal, UMG would merge with Pershing Square SPARC Holdings Ltd and re-emerge as a Nevada-based entity listed on the New York Stock Exchange. The move is designed to boost investor visibility and potentially secure inclusion in major indices such as the S&P 500.
Pershing Square Capital Management ceo Bill Ackman argued that while UMG’s operational performance remains strong, its market valuation has lagged due to external factors. “UMG’s stock price has languished due to a combination of issues that are unrelated to the performance of its music business,” Ackman said, pointing to concerns ranging from shareholder overhang to delayed US listing plans.
Ackman also flagged what he sees as untapped potential in UMG’s balance sheet and a lack of clear capital allocation strategy. He added that the market has not fully recognised the value of UMG’s €2.7 billion stake in Spotify, alongside gaps in investor communication.
The proposed transaction would also result in the cancellation of around 17 per cent of UMG’s outstanding shares, while maintaining its investment-grade balance sheet. Pershing Square has said it will fully backstop the equity financing, with debt commitments secured at signing. The deal is targeted for completion by the end of the year.
UMG, however, has struck a measured tone. The company confirmed that its board has received the non-binding proposal and will review it with advisers. It reiterated confidence in its current strategy and leadership under Lucian Grainge, signalling no immediate shift in stance.
The proposal comes at a time when global music companies are navigating evolving investor expectations, streaming economics and capital allocation pressures. For Pershing Square, the bet is clear: sharpen the financial story, relist in the US, and let the music play louder in the markets.
Whether UMG’s board is ready to change the tune remains to be seen, but the spotlight on its valuation just got a lot brighter.
